Today on Unscripted, guest host Denise Wolff, PharmD, CEO & Founder of Denise & Co., LLC, welcomes Zachary Contreras, PharmD, RPh, Director of Pharmacy Benefits, Sharp Health Plan, for a discussion on idiopathic hypersomnia (IH), a chronic neurological sleep disorder that remains widely underrecognized despite its profound impact on patients’ lives. Together, they explore the challenges of diagnosing IH, including a diagnostic delay that can exceed a decade, the significant burden the condition places on work, relationships, education, and overall quality of life, and the reasons many patients remain invisible within healthcare systems. The episode highlights practical steps health plans can take today to reduce barriers to care, improve long-term outcomes, and help patients with idiopathic hypersomnia receive the diagnosis and treatment they need sooner. Sponsored by Jazz Pharmaceuticals.
In this episode of Unscripted, AMCP’s Mitzi Wasik (SVP, Practice Strategy & Innovation & AMCP Foundation Executive Director) and Cate Lockhart (Chief Science Officer, AMCP & Executive Director, Biologics & Biosimilars Collective Intelligence Consortium (BBCIC)), discuss where fragmentation occurs across the health care system and why pharmacists, payers, providers, and pathologists all play a critical role in fixing it.
In this episode, we talk with Franck Rahaghi, MD, MHS, Executive Director of Cardiopulmonary Global Medical Affairs at United Therapeutics, about pulmonary hypertension in interstitial lung disease (PH-ILD), a serious and often under-recognized condition at the intersection of two progressive diseases. We discuss the importance of early recognition, the role of multidisciplinary care, emerging treatment options, and what patients, clinicians, and payers should know to improve outcomes.
In this episode, we talk with Arash Mostaghimi, MD, MPA, MPH, Vice Chair of Clinical Trials and Innovation, Brigham & Women's Hospital Department of Dermatology. Dr. Mostaghimi discusses alopecia areata—an autoimmune disease that causes patchy or complete hair loss—its inflammatory basis, how severity is measured, and the profound psychosocial impacts on patients and families. He also reviews the latest FDA-approved therapies, evolving treatment guidelines, and what patients, clinicians, and payers should know as new options reshape care.
Interested in being a guest or know an expert? Let us know!
https://www.amcp.org/podcast
https://amcp.org/corporate-opportunities
In this episode, we talk with Aaron Crittenden, President of Rx Marketplace at GoodRx, about Community Link, a new program from GoodRx that empowers independent pharmacies through direct contracting, predictable pricing, and access to over 90 brand medication deals. Aaron explains how Community Link helps pharmacies stay competitive, provide affordable prescriptions for patients, and build more sustainable economics in today’s challenging marketplace.
In this episode of Unscripted, AMCP speaks with Dr. Harrison Nguyen, a double board-certified dermatologist and health economist, about the true scope of psoriasis. From overlooked symptoms and high-impact areas to the systemic nature of the disease, Dr. Nguyen explains why a personalized treatment strategy is essential. He also explores the economic case for early intervention and access to advanced therapies.
In this episode of Unscripted – The AMCP Podcast, Tonja Johnson – founder of the Beautifully Unblemished Vitiligo Support Group – shares her personal journey with vitiligo, from diagnosis and frustration to advocacy and empowerment. In recognition of World Vitiligo Day, this conversation explores the physical, emotional, and social challenges of living with the condition, the ongoing stigma and mental health impact, and the urgent need for health plans to treat vitiligo as more than cosmetic. This episode highlights how community, awareness, and managed care can come together to improve the lives of those affected.
Join us on this episode of Unscripted, the AMCP Podcast, as we explore the emerging role of artificial intelligence in managed care pharmacy. Our guest, Joe Honcz, RPh, MVA, MBA and Senior Vice President of Market Access at Petauri, shares insights from his time at Aetna’s Innovation Lab through to today’s cutting-edge applications—from AI-powered health concierges to streamlined prior authorizations and precision drug discovery. Discover how AI is transforming efficiency, patient empowerment, and the future of pharmacy practice.
Listen to the final of a three-part podcast on a new, non-pharmacological treatment for Chronic Idiopathic Constipation. Hear from our experts Dr. Christine Frissora, Gastroenterologist and Associate Professor of Clinical Medicine at NY Presbyterian Cornell University Medical Center, and Dr. Ken Schaecher, Chief Medical Officer emeritus at University of Utah Health Plans, Chief Medical Officer at a regional health plan, and practicing general internal medicine specialist.
AMCP Unscripted discusses a new, non-pharmacological treatment for chronic idiopathic constipation with Dr. Christine Frissora, gastroenterologist and associate professor of clinical medicine, at The NY Presbyterian Cornell University Medical Center and Dr. Ken Schaecher, chief medical officer emeritus, University of Utah Health Plans and chief medical officer at a regional health plan and practicing general internal medicine specialist.
AMCP Unscripted discusses a new, non-pharmacological treatment for Chronic Idiopathic Constipation with Dr. Christine Frissora, gastroenterologist and associate professor of clinical medicine, at The NY Presbyterian Cornell University Medical Center and Dr. Ken Schaecher, chief medical officer emeritus, University of Utah Health Plans and chief medical officer at a regional health plan and practicing general internal medicine specialist.